Originally published by our sister publication Gastroenterology & Endoscopy News
By Natasha Albaneze
CHARLOTTE, N.C.—Black patients with inflammatory bowel disease are less likely to be treated with immunomodulator or biologic therapies than white IBD patients, according to a recent study in a large U.S. cohort.
IBD is “increasingly seen among the different races and ethnicities in the United States,” noted the researchers, led by Khaled Alsabbagh